Dopamine receptor D3 (DRD3) gene rs6280 variant and risk for restless legs syndrome

Sleep Medicine

Volumn 14, Issue 4, 2013, Pages 382-384

  Jiménez Jiménez, Félix Javier ^a,b   Alonso Navarro, Hortensia ^a,b   Martínez, Carmen ^c   Zurdo, Martín ^d   Turpín Fenoll, Laura ^e   Millán, Jorge ^e   Adeva Bartolomé, Teresa ^f   Cubo, Esther ^g   Navacerrada, Francisco ^a   Calleja, Marisol ^a   Plaza Nieto, José Francisco ^a   Pilo de la Fuente, Belén ^a   Arroyo Solera, Margarita ^a   Rojo Sebastián, Ana ^b   Rubio, Lluisa ^b   Agúndez, José A G ^c   García Martín, Elena ^c  

^a Hospital Universitario del Sureste de Madrid   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c UNIVERSITY OF EXTREMADURA   (Spain)

^d HOSPITAL VIRGEN DEL PUERTO   (Spain)

^e HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

^f Unit of Neurology   (Spain)

^g HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FERRITIN; GLYCINE; SERINE;

ADULT; ALLELE; CAUCASIAN; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRD3 GENE; EXON; FAMILY HISTORY; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; RECEPTORS, DOPAMINE D3; RESTLESS LEGS SYNDROME; RISK FACTORS;

EID: 84875602704     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2012.11.009     Document Type: Letter

References (8)

1. Roco A., Jiménez-Jiménez F.J., Alonso-Navarro H., Martínez C., Zurdo M., Turpín-Fenoll L., et al. MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome. J Neural Transm 2012, [Epub ahead of print].
2. Stiasny-Kolster K., Möller J.C., Zschocke J., Bandmann O., Cassel W., Oertel W.H., et al. Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients. Mov Disord 2004, 19:192-196.
3. 3 receptor knock-out mice. J Neurosci 2004, 24:11337-11345.
4. Dowling P., Klinker F., Stadelmann C., Hasan K., Paulus W., Liebetanz D. Dopamine D3 receptor specifically modulates motor and sensory symptoms in iron-deficient mice. J Neurosci 2011, 31:70-77.
5. Zhao H., Zhu W., Pan T., Xie W., Zhang A., Ondo W.G., et al. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J Neurosci Res 2007, 85:1065-1076.
6. Desautels A., Turecki G., Montplaisir J., Brisebois K., Sequeira A., Adam B., et al. Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology 2002, 59:215-219.
7. Mylius V., Möller J.C., Strauch K., Oertel W.H., Stiasny-Kolster K. No significance of the COMT val158met polymorphism in restless legs syndrome. Neurosci Lett 2010, 473:151-154.
8. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology work shop at the National Institute of Health. Sleep Med 2003, 4:101-119.